5 Best Healthcare Stocks For the Long Term

3. QuidelOrtho Corporation (NASDAQ:QDEL)

PE Ratio (TTM): 5.26

Number of Hedge Fund Holders: 29

QuidelOrtho Corporation (NASDAQ:QDEL) is a California-based diagnostic healthcare products company. Earlier this month, QuidelOrtho Corporation (NASDAQ:QDEL) posted strong Q4 revenue guidance. QuidelOrtho Corporation (NASDAQ:QDEL) expects its revenue to come in the range of $853 million to $868 million, significantly above the consensus of $764.27 million. QuidelOrtho Corporation (NASDAQ:QDEL) said its COVID-19 product revenue was expected to total in the range of $124 million to $134 million. For full-year 2022, QuidelOrtho’s revenue is expected to be between $4.038 billion to $4.053 billion, above the consensus of $3.95 billion.

As of the end of the third quarter, 29 hedge funds tracked by Insider Monkey reported having stakes in QuidelOrtho Corporation (NASDAQ:QDEL), compared to 37 funds in the previous quarter. The total value of these stakes was $692 million.